Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Grazoprevir + Elbasvir in Liver Transplant Recipients With Recurrent Hepatitis C
2015-005453-13Phase 3Terminated
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of grazoprevir in hepatitis C virus infection, sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoints: Primary efficacy endpoint and Tolerability and safety. Started Jul 2016; status: terminated.
02
Drugs
grazoprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2015-005453-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005453-13.